Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography

[1]  M. Kiyosawa,et al.  Evaluation of carbon-11 labeled KF15372 and its ethyl and methyl derivatives as a potential CNS adenosine A1 receptor ligand. , 1997, Nuclear medicine and biology.

[2]  M. Kiyosawa,et al.  Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A(2A) receptors with positron emission tomography. , 2000, Nuclear medicine and biology.

[3]  M. Senda,et al.  Myocardial adenosine A2a receptor imaging of rabbit by PET with [11C]KF17837 , 1997, Annals of nuclear medicine.

[4]  E. Fuse,et al.  Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance. , 1993, Journal of medicinal chemistry.

[5]  M. Senda,et al.  11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Mauro Papotti,et al.  Immunohistochemical localization of adenosine A1 receptors in human brain regions , 2001, Neuroscience Letters.

[7]  M. Avoli,et al.  Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: A quantitative autoradiographic study , 1993, Neuroscience Letters.

[8]  S. Synder,et al.  Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  R. Faull,et al.  Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study , 1990, Neuroscience.

[10]  T. Dunwiddie,et al.  The Role and Regulation of Adenosine in the Central Nervous System , 2022 .

[11]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[12]  C. Cotman,et al.  Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in alzheimer hippocampus: A quantitative autoradiographic study , 1993, Neuroscience.

[13]  D. Lubitz.  Adenosine in the treatment of stroke: yes, maybe, or absolutely not? , 2001 .

[14]  E. Broussolle,et al.  Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease , 2001, Neurophysiologie Clinique/Clinical Neurophysiology.

[15]  F Suzuki,et al.  (E)-1,3-dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists. , 1992, Journal of medicinal chemistry.

[16]  J. Fastbom,et al.  Adenosine A1 receptors in the human brain: A quantitative autoradiographic study , 1987, Neuroscience.

[17]  E. Wolters,et al.  IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism. , 1997, Journal of neural transmission. Supplementum.

[18]  B. Fredholm,et al.  Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography , 1995, Neuropharmacology.

[19]  H Toyama,et al.  Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist. , 1996, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[20]  B. Fredholm,et al.  Pharmacology of adenosine A2A receptors. , 1996, Trends in pharmacological sciences.

[21]  H. Kase,et al.  Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine. , 1993, Journal of medicinal chemistry.

[22]  M. E. Lewis,et al.  Autoradiographic visualization of rat brain adenosine receptors using N6-cyclohexyl [3H]adenosine. , 1981, European journal of pharmacology.

[23]  S. Schiffmann,et al.  Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.

[24]  Helmut L. Haas,et al.  Functions of neuronal adenosine receptors , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[25]  H Toyama,et al.  A PET study of adenosine A1 receptor in anesthetized monkey brain. , 2000, Nuclear medicine and biology.

[26]  M. Senda,et al.  Evaluation of carbon-11-labeled KF17837: a potential CNS adenosine A2a receptor ligand. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  G. Wooten,et al.  Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons , 1993, Brain Research.

[28]  M. Senda,et al.  Synthesis and in vivo evaluation of [11C]semotiadil, a benzothiazine calcium antagonist. , 1994, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[29]  K. Ishiwata,et al.  Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy. , 1991, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[30]  J. Fastbom,et al.  The distribution of adenosine a1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals , 1987, Neuroscience.

[31]  Keiichi Oda,et al.  Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: Comparison with the dopamine receptor imaging , 2002, Annals of nuclear medicine.

[32]  M. Senda,et al.  Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist. , 1996, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[33]  J. Málly,et al.  Potential role of adenosine antagonist therapy in pathological tremor disorders. , 1996, Pharmacology & therapeutics.

[34]  B B Fredholm,et al.  Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study , 1997, Synapse.

[35]  B. Fredholm,et al.  Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[36]  T. Yamashita,et al.  A high resolution PET for animal studies , 1991, Conference Record of the 1991 IEEE Nuclear Science Symposium and Medical Imaging Conference.

[37]  C. Gerfen,et al.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.

[38]  Stoessl Aj,et al.  NEURORECEPTOR IMAGING : NEW DEVELOPMENTS IN PET AND SPECT IMAGING OF NEURORECEPTOR BINDING (INCLUDING DOPAMINE TRANSPORTERS, VESICLE TRANSPORTERS AND POST SYNAPTIC RECEPTOR SITES) , 1998 .

[39]  Selective adenosine antagonists for mapping central nervous system adenosine receptors with positron emission tomography: Carbon‐11 labeled KF15372 (A1) and KF17837 (A2A) , 1998 .

[40]  K. Kubo,et al.  Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure. , 1992, Journal of medicinal chemistry.

[41]  K. Kubo,et al.  8-(Dicyclopropylmethyl)-1,3-dipropylxanthine: a potent and selective adenosine A1 antagonist with renal protective and diuretic activities. , 1991, Journal of medicinal chemistry.

[42]  Tadashi Nariai,et al.  Mapping adenosine A1 receptors in the cat brain by positron emission tomography with [11C]MPDX , 2002 .

[43]  M. Kiyosawa,et al.  Carbon-11-labeled KF15372: a potential central nervous system adenosine A1 receptor ligand. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  H. Watabe,et al.  Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals. , 1991, Journal of radiation research.

[45]  M. Senda,et al.  Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 within vitro autoradiography andin vivo tissue uptake , 2000, Annals of nuclear medicine.

[46]  Evaluation of iodinated and brominated [11C]styrylxanthine derivatives asin vivo radioligands mapping adenosine A2A receptor in the central nervous system , 2000, Annals of nuclear medicine.

[47]  H. Kase.  New Aspects of Physiological and Pathophysiological Functions of Adenosine A2A Receptor in Basal Ganglia , 2001, Bioscience, biotechnology, and biochemistry.

[48]  S. Augood,et al.  Adenosine A2a receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: a co-expression study. , 1994, Brain research. Molecular brain research.

[49]  K. Ishii,et al.  Assessment of adenosine A2A receptors with PET as a new diagnostic tool for neurological disorders , 2002 .

[50]  M. Kiyosawa,et al.  Neuroreceptor bindings and synaptic activity in visual system of monocularly enucleated rat. , 2001, Japanese journal of ophthalmology.

[51]  S. File,et al.  Depletion in amygdaloid 5-hydroxytryptamine concentration and changes in social and aggressive behaviour , 2005, Journal of Neural Transmission.